Lazard Asset Management LLC Cellectis S.A. Transaction History

Lazard Asset Management LLC

$72.9 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$10.15 - $16.89 $1.55 Million - $2.58 Million	-152,558 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$14.6 - $20.6 $344,049 - $485,439	-23,565 Reduced 13.38%	152,558 $2.38 Million
Q1 2019 May 13, 2019	BUY	$15.53 - $19.75 $535,785 - $681,375	34,500 Added 24.36%	176,123 $3.23 Million
Q4 2018 Feb 13, 2019	BUY	$15.58 - $28.41 $46,428 - $84,661	2,980 Added 2.15%	141,623 $2.36 Million
Q3 2018 Nov 13, 2018	SELL	$25.99 - $30.6 $792,279 - $932,810	-30,484 Reduced 18.02%	138,643 $3.91 Million
Q2 2018 Aug 13, 2018	BUY	$27.78 - $38.53 $456,592 - $633,279	16,436 Added 10.76%	169,127 $4.78 Million
Q1 2018 May 14, 2018	BUY	$27.78 - $35.19 $54,032 - $68,444	1,945 Added 1.29%	152,691 $4.81 Million
Q4 2017 Feb 13, 2018	SELL	$23.33 - $35.01 $1.47 Million - $2.21 Million	-63,071 Reduced 29.5%	150,746 $4.39 Million
Q3 2017 Nov 13, 2017	SELL	$21.65 - $32.18 $1.14 Million - $1.7 Million	-52,715 Reduced 19.78%	213,817 $6.08 Million
Q2 2017 Aug 19, 2019	SELL	N/A	-32,502 Reduced 10.87%	266,532 $6.88 Million
Q1 2017 Aug 13, 2019	SELL	N/A	-1,720 Reduced 0.57%	299,034 $7.18 Million
Q4 2016 Jul 30, 2019	BUY	N/A	15,285 Added 5.35%	300,754 $5.1 Million
Q3 2016 Aug 07, 2019	BUY	N/A	10,120 Added 3.68%	285,469 $6.87 Million
Q2 2016 Jul 29, 2019	BUY	N/A	16,286 Added 6.29%	275,349 $7.32 Million
Q1 2016 Jul 25, 2019	SELL	N/A	-3,275 Reduced 1.25%	259,063 $7.12 Million
Q4 2015 Jul 24, 2019	BUY	N/A	68,943 Added 35.65%	262,338 $8.14 Million
Q3 2015 Jul 15, 2019	SELL	N/A	-3,958 Reduced 2.01%	193,395 $5.1 Million
Q2 2015 Jul 08, 2019	BUY	N/A	197,353	197,353 $7.12 Million

Others Institutions Holding CLLS

# of Institutions

Shares Held

11.2M

Call Options Held

2.8K

Put Options Held

17.9K

Long Focus Capital Management, LLC San Juan, PR

4.62M
Shares

$8.73 Million
0.35% of portfolio
Capital International Investors Los Angeles, CA

1.85M
Shares

$3.49 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.44M
Shares

$2.72 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

1.44M
Shares

$2.72 Million
0.0% of portfolio
Baillie Gifford & CO

708K
Shares

$1.34 Million
0.0% of portfolio

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $86M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account